Insider buying · SEC Form 4

Insider Buying — Aug 5, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

3insider buys
$10.7Mbought in total
3companies
1by CEOs, CFOs and other chiefs
COElargest: $8.06M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
COE51Talk Online Education GroupHuang Jack JiajiaCEO$8.06M473,520$17.02AddedAug 5, 2026
Form 4 ↗
Rule 10b5-1 plan via HH Talent Limited; 3 tranches Jul 28-30 at $16.88/$16.91/$17.21 per ADS (wtd avg $17.02). Each ADS = 60 Class A ordinary shares. COE now $18.76 (+10.2% vs buy). CEO holds 7.3M direct + 42.25M+ via Dasheng Global Limited.
GSHDGoosehead Insurance, Inc.Durable Capital Partners LP10% Owner$2.25M36,256$61.96AddedAug 4, 2026
Form 4 ↗
Investment adviser to Durable Capital Master Fund LP; 2 tranches Jul 31 at $61.88 (22,764 sh) and $62.00 (13,492 sh); wtd avg $61.94. Now holds 2,570,260 shares. GSHD now $68.56 (+10.7% vs buy).
ACOGAlpha Cognition Inc.Opaleye Management Inc.10% Owner$423K52,900$8.00AddedAug 4, 2026
Form 4 ↗
Investment adviser to Opaleye L.P.; 2,900 sh at $7.92 (Jul 31) + 50,000 sh at $8.00 (Aug 3); wtd avg $7.99. Now holds 3,048,223+ shares. ACOG now $8.94 (+11.9% vs Aug 3 buy). Alzheimer's biotech with Zunveyl approved.

AIThe day in insider buying

SEC Form 4 Insider Scan — August 5, 2026

Scanned the last 24 hours of EDGAR Form 4 filings (Aug 4–5, 2026). 3 qualifying buys (≥ $250K, transaction type P) totalling $10.7M.

Headline filings

  • COE — Huang Jack Jiajia (CEO) bought 473,520 ADS ≈ $8.1M at $16.88–$17.21 avg (wtd avg $17.02/ADS); now $18.76 (+10.2% since buy). (filing)
  • GSHD — Durable Capital Partners LP (10% Owner) bought 36,256 shares ≈ $2.25M at $61.94 wtd avg; now $68.56 (+10.7% since buy). (filing)
  • ACOG — Opaleye Management Inc. (10% Owner) bought 52,900 shares ≈ $423K at $7.99 wtd avg; now $8.94 (+11.9% since buy). (filing)

Notes

Light-volume scan day — only 3 qualifying open-market purchases across all Form 4 filings from Aug 4–5, consistent with the mid-summer lull. All three insiders are sitting in the green already.

COE (51Talk Online Education) is the headline. CEO Huang Jack Jiajia has been executing a Rule 10b5-1 buying plan via HH Talent Limited, accumulating $8.1M in ADS across three sessions (Jul 28–30). He directly holds 7.3M shares and affiliates control 42.25M+ more — this is systematic conviction, not a one-off. Filing arrived 5 days after last trade date, suggesting the CEO's team batched the report. COE now at $18.76, +10.2% above the weighted-avg buy price. Each ADS represents 60 Class A ordinary shares.

GSHD (Goosehead Insurance) — Durable Capital Partners LP, the quality-growth fund known for long-horizon bets, added 36,256 shares at $61.88–$62.00 on Jul 31, filed Aug 4. Durable now holds 2.57M shares (≈3.6% of the company). This is patient, hands-on-the-wheel positioning from a fund that rarely trades — a meaningful signal. GSHD at $68.56 is +10.7% above the buy price.

ACOG (Alpha Cognition) — Opaleye Management, a specialist biotech fund, bought two tranches (2,900 shares Jul 31 at $7.92 + 50,000 shares Aug 3 at $8.00 = 52,900 total). They now hold 3.05M+ shares, making them the largest external shareholder. Opaleye has deep domain expertise in small-cap biotech — repeat buying here warrants attention. ACOG at $8.94 is +11.9% above the larger Aug 3 tranche. Alzheimer's-focused pipeline with Zunveyl approved.

Most-bought stocks, last 30 days

  • AVO $60.1M · 8 buysMission Produce, Inc.
  • SCTX $56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
  • COE $34.8M · 4 buys, 2 insiders51Talk Online Education Group
  • MPLT $15.3M · 1 buyMapLight Therapeutics, Inc.
  • FLUT $11.8M · 1 buyFlutter Entertainment plc
  • LBRX $10.0M · 1 buyLB Pharmaceuticals Inc.
  • NTSK $7.53M · 2 buys, 2 insidersNetskope Inc.
  • PBLS $6.92M · 1 buyParabilis Medicines, Inc.
  • HDSN $4.87M · 2 buysHudson Technologies, Inc.
  • GLOO $3.50M · 1 buyGloo Holdings, Inc.
  • ARTV $2.58M · 1 buyArtiva Biotherapeutics, Inc.
  • ACI $2.41M · 2 buys, 2 insidersAlbertsons Companies, Inc.
  • GSHD $2.25M · 1 buyGoosehead Insurance, Inc.
  • CLBK $2.13M · 5 buys, 5 insidersColumbia Financial, Inc.
  • GGAL $2.09M · 1 buyGrupo Financiero Galicia S.A.
  • ENR $2.02M · 1 buyEnergizer Holdings, Inc.
  • RH $1.83M · 1 buyRH
  • FULC $1.48M · 2 buys, 2 insidersFulcrum Therapeutics, Inc.
  • NVCT $1.17M · 2 buys, 2 insidersNuvectis Pharma, Inc.
  • CRDF $1.00M · 1 buyCardiff Oncology Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.